IR-Med Inc. (IRME)
OTCMKTS · Delayed Price · Currency is USD
0.0151
+0.0031 (26.21%)
At close: Aug 26, 2025

IR-Med Company Description

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications.

The company’s development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children.

IR-Med Inc. is headquartered in Rosh Pinna, Israel.

IR-Med Inc.
CountryUnited States
IndustryMedical Devices
SectorHealthcare
Employees4
CEORan Ziskind

Contact Details

Address:
ZHR Industrial Zone
Rosh Pinna, Nevada 1231400
Israel
Phone972 4 655 5054
Websiteir-medical.com

Stock Details

Ticker SymbolIRME
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS46265R1032
SIC Code3841

Key Executives

NamePosition
Ran ZiskindChief Executive Officer
Oded BashanCo-Founder and Chairman
Aharon KleinCo-Founder, Chief Technology Officer and Director